Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
15/10/2025 18:12
Oct 15 (Reuters) - Adocia SA ADOC.PA: ADOCIA REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ADOCIA SA - CASH RUNWAY SECURED UNTIL Q2 2026 ADOCIA SA: NOW SEEING CHALLENGES WITH GLP-1, AMYLIN, AND OTHER METABOLIC PEPTIDES Source text: ID:nBw52Fl88a Further company coverage: ADOC.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro